| P50 | author | Matthew Tutton | Q95642767 |
| P2093 | author name string | Sarah Burton | |
| | Suzanne A. Eccles | |
| | Mark L. George | |
| | R. Ian Swift | |
| | A. Muti Abulafi | |
| P2860 | cites work | Plasma assay of gelatinase B: tissue inhibitor of metalloproteinase complexes in cancer | Q28278066 |
| | Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues. Clinical and experimental applications | Q33692926 |
| | Unique activation of matrix metalloproteinase-9 within human liver metastasis from colorectal cancer | Q36115177 |
| | Expression of tissue inhibitor of metalloproteinases TIMP-2 in human colorectal cancer--a predictor of tumour stage | Q36431093 |
| | Prediction of colorectal cancer relapse and survival via tissue RNA levels of matrix metalloproteinase-9. | Q36836819 |
| | Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer | Q38478473 |
| | Colocalisation of matrix metalloproteinase-9-mRNA and protein in human colorectal cancer stromal cells | Q40027360 |
| | Plasma assay of matrix metalloproteinases (MMPs) and MMP-inhibitor complexes in cancer. Potential use in predicting metastasis and monitoring treatment | Q40642347 |
| | Spectrum of matrix metalloproteinase expression in primary and metastatic colon cancer: relationship to the tissue inhibitors of metalloproteinases and membrane type-1-matrix metalloproteinase. | Q40799982 |
| | Changing views of the role of matrix metalloproteinases in metastasis | Q41592276 |
| | Correlation between expression of matrix metalloproteinase-2 (MMP-2), and matrix metalloproteinase-9 (MMP-9) and angiogenesis in colorectal adenocarcinoma | Q42030982 |
| | Loss of basement membrane type IV collagen is associated with increased expression of metalloproteinases 2 and 9 (MMP-2 and MMP-9) during human colorectal tumorigenesis. | Q53423509 |
| | Zymographic analysis of circulating and tissue forms of colon carcinoma gelatinase A (MMP-2) and B (MMP-9) separated by mono- and two-dimensional electrophoresis | Q60808984 |
| | Distribution of gelatinase B (MMP-9) and type IV collagen in colorectal carcinoma | Q62056258 |
| | Metalloproteinases and Tissue Inhibitors of Matrix-Metalloproteinases in Plasma of Patients with Prostate Cancer and in Prostate Cancer Tissue | Q62632572 |
| | M(r) 92,000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer | Q70521319 |
| | Enhanced expression of tissue inhibitors of metalloproteinases in human colorectal tumors | Q71733821 |
| | Matrilysin is associated with progression of colorectal tumor | Q71768421 |
| | Immunohistochemical localization of matrix metalloproteinase 2 and its specific inhibitor TIMP-2 in neoplastic tissues with monoclonal antibodies | Q72253829 |
| | Elevated levels of serum and plasma metalloproteinases in patients with gastric cancer | Q73496785 |
| | Matrix metalloproteinases, their tissue inhibitors and colorectal cancer staging | Q74260950 |
| | Serum matrix metalloproteinase-2 and its density in men with prostate cancer as a new predictor of disease extension | Q74292680 |
| | Plasma concentration of tissue inhibitor of matrix metalloproteinase 1 in patients with colorectal carcinoma | Q77332036 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | oncology | Q162555 |
| | colorectal cancer | Q188874 |
| | colorectal carcinoma | Q25493920 |
| P1104 | number of pages | 10 | |
| P304 | page(s) | 541-550 | |
| P577 | publication date | 2003-11-01 | |
| | 2003-11-20 | |
| P1433 | published in | International Journal of Cancer | Q332492 |
| P1476 | title | Use of plasma MMP-2 and MMP-9 levels as a surrogate for tumour expression in colorectal cancer patients | |
| | Use of plasma MMP‐2 and MMP‐9 levels as a surrogate for tumour expression in colorectal cancer patients | |
| P478 | volume | 107 | |